SV Health Investors, LLC

Q3 2016 13F Holdings Report, Stock Holdings

Signature - Title
Brent M. Faduski - Officer
Location
Boston, MA
Holdings as of
September 30, 2016
Value $
$130M
Num holdings
6
Date filed
11/14/2016, 08:16 AM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q2 2016 - Aug 12, 2016
Next filing
Q4 2016 - Feb 7, 2017
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2016 Q3 compared to 2016 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Denise W. Marks CFO Boston, Massachusetts 11/14/2016

The filing of this report shall not be deemed an admission, for purposes of Section 13(f), 13(d), 13(g), or 16(a) under the Securities Exchange Act of 1934, as amended, and the rules thereunder, or for any other purpose, that the Reporting Manager or any other person (including Other Managers or Other Included Managers named herein) is the beneficial owner of any securities. SV Life Sciences Advisers, LLC, a Delaware limited liability company ("Advisers"), is an institutional investment manager subject to Section 13(f) of the Securities Exchange Act of 1934 and the rules promulgated thereunder. SV Life Sciences Fund IV, L.P. ("SVLS IV LP") and SV Life Sciences Fund IV Strategic Partners, L.P. ("Strategic Partners IV" and together with SVLS IV LP, the "Fund IV Entities"), and International Life Sciences Fund III (LP 1), L.P. ("ILSF LP1"), International Life Sciences Fund III Co- Investment, L.P. ("ILSF Co-Invest"), and International Life Sciences Fund III Strategic Partners, L.P. ("ILSF Strategic" and together with ILSF LP1 and ILSF Co-Invest, the "Fund III Entities"), and SV Life Sciences Fund V, L.P. ("SVLS V LP") and SV Life Sciences Fund V Strategic Partners, L.P. ("Strategic Partners V" and together with SVLS V LP, the "Fund V Entities"), which are each Delaware limited partnerships (the Fund IV Entities, the Fund III Entities and the Fund V Entities together, the "Funds"), directly own certain security positions reported by Advisers, which is the investment adviser of the Funds. SV Life Sciences Fund IV (GP), L.P., a Delaware limited partnership ("SVLS IV GP") is the general partner of the Fund IV Entities, and SVLSF IV, LLC, a Delaware limited liability company is the general partner of SVLS IV GP. Certain of the security positions reported by Advisers are also being reported by SVLS IV GP and SVLSF IV, LLC. Each of SVLS IV GP, SVLSF IV, LLC and Advisers may be deemed to share voting power and control over the shares held by the Fund IV Entities. Advisers may be deemed to share voting power and control over the shares held by the Fund III Entities and the Fund V Entities. Each of SVLS IV GP, SVLSF IV, LLC and Advisers disclaim beneficial ownership of the shares held by the Funds except to the extent of any pecuniary interest therein.

List of Other Managers Reporting for SV Health Investors, LLC:

Name Holdings Value Location File Number
SV Life Sciences Fund VI (GP), L.P. Boston, MA 028-19255
SVLSF VI, LLC Boston, MA 028-19256

Other Included Managers (2):

Num Name File Number
1 SVLSF IV, LLC 028-16272
2 SV Life Sciences Fund IV (GP), L.P. 028-16273